SageView Advisory Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$215K Buy
+579
New +$204K 0.01% 566
2026
Q1
– Sell
-230
Closed -$63.3K – 2443
2025
Q4
$63.3K Buy
+230
New +$62.9K ﹤0.01% 982
2024
Q2
– Sell
-769
Closed -$332K – 812
2024
Q1
$332K Buy
+769
New +$284K 0.02% 393

Other funds holding WST

SageView Advisory Group's WST Position: Q3 2026 in Review

SageView Advisory Group opened a new position in West Pharmaceutical (WST) in Q3 2026: 579 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #566 among its holdings. This is a return to the name: SageView Advisory Group previously reported a position in WST as recently as Q4 2025.

SageView Advisory Group first reported a position in WST in Q1 2024 and has held it in 3 quarters since. The position peaked at $332K in Q1 2024. 878 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • SageView Advisory Group held 579 shares of West Pharmaceutical worth $215K as of Q3 2026.
  • West Pharmaceutical was a new SageView Advisory Group position in Q3 2026.
  • West Pharmaceutical made up 0.01% of SageView Advisory Group's portfolio in Q3 2026, its #566 holding.
  • SageView Advisory Group first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • SageView Advisory Group's West Pharmaceutical position peaked at $332K in Q1 2024.
  • 878 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on SageView Advisory Group's 13F filing for Q3 2026, filed 16 Nov 2026.